nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—Lisdexamfetamine—Lisinopril—dilated cardiomyopathy	0.144	0.365	CrCrCtD
Lacosamide—Nateglinide—Lisinopril—dilated cardiomyopathy	0.128	0.326	CrCrCtD
Lacosamide—Aspartame—Lisinopril—dilated cardiomyopathy	0.122	0.309	CrCrCtD
Lacosamide—CA14—Furosemide—dilated cardiomyopathy	0.0947	0.187	CbGbCtD
Lacosamide—CA6—Furosemide—dilated cardiomyopathy	0.09	0.177	CbGbCtD
Lacosamide—CA5B—Furosemide—dilated cardiomyopathy	0.0784	0.155	CbGbCtD
Lacosamide—CA9—Furosemide—dilated cardiomyopathy	0.0673	0.133	CbGbCtD
Lacosamide—CA1—Furosemide—dilated cardiomyopathy	0.063	0.124	CbGbCtD
Lacosamide—CA4—Furosemide—dilated cardiomyopathy	0.0592	0.117	CbGbCtD
Lacosamide—CA2—Furosemide—dilated cardiomyopathy	0.0544	0.107	CbGbCtD
Lacosamide—CA5B—sinoatrial node—dilated cardiomyopathy	0.0139	0.346	CbGeAlD
Lacosamide—CA3—pericardium—dilated cardiomyopathy	0.00823	0.206	CbGeAlD
Lacosamide—CA3—cardiac ventricle—dilated cardiomyopathy	0.00194	0.0484	CbGeAlD
Lacosamide—CA3—myocardium—dilated cardiomyopathy	0.00182	0.0455	CbGeAlD
Lacosamide—CA14—cardiac ventricle—dilated cardiomyopathy	0.00176	0.044	CbGeAlD
Lacosamide—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.00172	0.0374	CcSEcCtD
Lacosamide—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.00158	0.0344	CcSEcCtD
Lacosamide—SCN9A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00157	0.125	CbGpPWpGaD
Lacosamide—SCN3A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.00151	0.12	CbGpPWpGaD
Lacosamide—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0014	0.111	CbGpPWpGaD
Lacosamide—CA3—heart—dilated cardiomyopathy	0.00127	0.0318	CbGeAlD
Lacosamide—CA14—heart—dilated cardiomyopathy	0.00115	0.0289	CbGeAlD
Lacosamide—CA3—cardiac atrium—dilated cardiomyopathy	0.00109	0.0272	CbGeAlD
Lacosamide—Ataxia—Spironolactone—dilated cardiomyopathy	0.001	0.0219	CcSEcCtD
Lacosamide—CA14—cardiac atrium—dilated cardiomyopathy	0.000988	0.0247	CbGeAlD
Lacosamide—Injection site pain—Furosemide—dilated cardiomyopathy	0.000979	0.0213	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000961	0.0209	CcSEcCtD
Lacosamide—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.000923	0.0201	CcSEcCtD
Lacosamide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000913	0.0199	CcSEcCtD
Lacosamide—CA4—cardiac ventricle—dilated cardiomyopathy	0.000849	0.0212	CbGeAlD
Lacosamide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000815	0.0178	CcSEcCtD
Lacosamide—CA5B—heart—dilated cardiomyopathy	0.000808	0.0202	CbGeAlD
Lacosamide—CA4—myocardium—dilated cardiomyopathy	0.000799	0.02	CbGeAlD
Lacosamide—SCN3A—heart—dilated cardiomyopathy	0.000785	0.0196	CbGeAlD
Lacosamide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000767	0.0167	CcSEcCtD
Lacosamide—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000764	0.0167	CcSEcCtD
Lacosamide—CA1—heart—dilated cardiomyopathy	0.000714	0.0178	CbGeAlD
Lacosamide—CA2—cardiac ventricle—dilated cardiomyopathy	0.000704	0.0176	CbGeAlD
Lacosamide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000698	0.0152	CcSEcCtD
Lacosamide—CA5B—cardiac atrium—dilated cardiomyopathy	0.000691	0.0173	CbGeAlD
Lacosamide—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000683	0.0149	CcSEcCtD
Lacosamide—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000673	0.0147	CcSEcCtD
Lacosamide—CA2—myocardium—dilated cardiomyopathy	0.000663	0.0166	CbGeAlD
Lacosamide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000618	0.0135	CcSEcCtD
Lacosamide—SCN9A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.000604	0.0482	CbGpPWpGaD
Lacosamide—SCN3A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.000578	0.0461	CbGpPWpGaD
Lacosamide—CA4—heart—dilated cardiomyopathy	0.000558	0.0139	CbGeAlD
Lacosamide—Irritability—Furosemide—dilated cardiomyopathy	0.000554	0.0121	CcSEcCtD
Lacosamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00054	0.0118	CcSEcCtD
Lacosamide—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.000535	0.0427	CbGpPWpGaD
Lacosamide—Confusional state—Spironolactone—dilated cardiomyopathy	0.000529	0.0115	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000523	0.0114	CcSEcCtD
Lacosamide—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000497	0.0108	CcSEcCtD
Lacosamide—CA4—cardiac atrium—dilated cardiomyopathy	0.000477	0.0119	CbGeAlD
Lacosamide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000466	0.0102	CcSEcCtD
Lacosamide—CA2—heart—dilated cardiomyopathy	0.000462	0.0116	CbGeAlD
Lacosamide—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00046	0.01	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000453	0.00987	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000443	0.00967	CcSEcCtD
Lacosamide—Diplopia—Lisinopril—dilated cardiomyopathy	0.000435	0.00949	CcSEcCtD
Lacosamide—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000435	0.00949	CcSEcCtD
Lacosamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000432	0.00942	CcSEcCtD
Lacosamide—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000423	0.00922	CcSEcCtD
Lacosamide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000417	0.0091	CcSEcCtD
Lacosamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000417	0.00908	CcSEcCtD
Lacosamide—Irritability—Lisinopril—dilated cardiomyopathy	0.000416	0.00906	CcSEcCtD
Lacosamide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000414	0.00903	CcSEcCtD
Lacosamide—Ataxia—Lisinopril—dilated cardiomyopathy	0.000409	0.00893	CcSEcCtD
Lacosamide—CA2—cardiac atrium—dilated cardiomyopathy	0.000396	0.00988	CbGeAlD
Lacosamide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000392	0.00855	CcSEcCtD
Lacosamide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000386	0.00842	CcSEcCtD
Lacosamide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00038	0.00827	CcSEcCtD
Lacosamide—Eye disorder—Furosemide—dilated cardiomyopathy	0.000375	0.00818	CcSEcCtD
Lacosamide—Tinnitus—Furosemide—dilated cardiomyopathy	0.000374	0.00816	CcSEcCtD
Lacosamide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000373	0.00812	CcSEcCtD
Lacosamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000371	0.00809	CcSEcCtD
Lacosamide—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000363	0.0079	CcSEcCtD
Lacosamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000359	0.00782	CcSEcCtD
Lacosamide—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000352	0.00767	CcSEcCtD
Lacosamide—Erythema—Furosemide—dilated cardiomyopathy	0.00035	0.00762	CcSEcCtD
Lacosamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000347	0.00756	CcSEcCtD
Lacosamide—Flatulence—Furosemide—dilated cardiomyopathy	0.000344	0.00751	CcSEcCtD
Lacosamide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000336	0.00732	CcSEcCtD
Lacosamide—Depression—Lisinopril—dilated cardiomyopathy	0.000335	0.00729	CcSEcCtD
Lacosamide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000333	0.00727	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000333	0.00725	CcSEcCtD
Lacosamide—Rash—Spironolactone—dilated cardiomyopathy	0.000331	0.00721	CcSEcCtD
Lacosamide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00033	0.0072	CcSEcCtD
Lacosamide—Vision blurred—Furosemide—dilated cardiomyopathy	0.000329	0.00718	CcSEcCtD
Lacosamide—Headache—Spironolactone—dilated cardiomyopathy	0.000328	0.00716	CcSEcCtD
Lacosamide—Anaemia—Furosemide—dilated cardiomyopathy	0.000323	0.00704	CcSEcCtD
Lacosamide—Agitation—Furosemide—dilated cardiomyopathy	0.000321	0.007	CcSEcCtD
Lacosamide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000317	0.00692	CcSEcCtD
Lacosamide—Vertigo—Furosemide—dilated cardiomyopathy	0.000314	0.00684	CcSEcCtD
Lacosamide—Amphetamine—SLC22A5—dilated cardiomyopathy	0.000314	0.519	CrCbGaD
Lacosamide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000313	0.00683	CcSEcCtD
Lacosamide—Nausea—Spironolactone—dilated cardiomyopathy	0.000311	0.00679	CcSEcCtD
Lacosamide—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000307	0.00668	CcSEcCtD
Lacosamide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000301	0.00657	CcSEcCtD
Lacosamide—Hallucination—Lisinopril—dilated cardiomyopathy	0.0003	0.00653	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000296	0.00644	CcSEcCtD
Lacosamide—Dry mouth—Furosemide—dilated cardiomyopathy	0.000291	0.00634	CcSEcCtD
Lacosamide—Methamphetamine—SLC22A5—dilated cardiomyopathy	0.000291	0.481	CrCbGaD
Lacosamide—Confusional state—Furosemide—dilated cardiomyopathy	0.000288	0.00627	CcSEcCtD
Lacosamide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000285	0.00621	CcSEcCtD
Lacosamide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000281	0.00612	CcSEcCtD
Lacosamide—Shock—Furosemide—dilated cardiomyopathy	0.000281	0.00612	CcSEcCtD
Lacosamide—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00028	0.0061	CcSEcCtD
Lacosamide—Skin disorder—Furosemide—dilated cardiomyopathy	0.000277	0.00604	CcSEcCtD
Lacosamide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000276	0.00601	CcSEcCtD
Lacosamide—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000264	0.00575	CcSEcCtD
Lacosamide—Erythema—Lisinopril—dilated cardiomyopathy	0.000262	0.00572	CcSEcCtD
Lacosamide—Flatulence—Lisinopril—dilated cardiomyopathy	0.000258	0.00563	CcSEcCtD
Lacosamide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000256	0.00558	CcSEcCtD
Lacosamide—Somnolence—Furosemide—dilated cardiomyopathy	0.000254	0.00553	CcSEcCtD
Lacosamide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000252	0.0055	CcSEcCtD
Lacosamide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000247	0.00539	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000246	0.00537	CcSEcCtD
Lacosamide—Fatigue—Furosemide—dilated cardiomyopathy	0.000246	0.00536	CcSEcCtD
Lacosamide—Tremor—Lisinopril—dilated cardiomyopathy	0.000246	0.00536	CcSEcCtD
Lacosamide—Constipation—Furosemide—dilated cardiomyopathy	0.000244	0.00532	CcSEcCtD
Lacosamide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000242	0.00528	CcSEcCtD
Lacosamide—Angioedema—Lisinopril—dilated cardiomyopathy	0.00024	0.00522	CcSEcCtD
Lacosamide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000236	0.00514	CcSEcCtD
Lacosamide—Syncope—Lisinopril—dilated cardiomyopathy	0.000235	0.00513	CcSEcCtD
Lacosamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000235	0.00512	CcSEcCtD
Lacosamide—Palpitations—Lisinopril—dilated cardiomyopathy	0.000232	0.00505	CcSEcCtD
Lacosamide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00023	0.00502	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000228	0.0182	CbGpPWpGaD
Lacosamide—Urticaria—Furosemide—dilated cardiomyopathy	0.000227	0.00494	CcSEcCtD
Lacosamide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000225	0.00492	CcSEcCtD
Lacosamide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000223	0.00487	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000222	0.00483	CcSEcCtD
Lacosamide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000221	0.00481	CcSEcCtD
Lacosamide—SCN3A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000218	0.0174	CbGpPWpGaD
Lacosamide—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000218	0.00476	CcSEcCtD
Lacosamide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000216	0.0047	CcSEcCtD
Lacosamide—SCN9A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000215	0.0171	CbGpPWpGaD
Lacosamide—Shock—Lisinopril—dilated cardiomyopathy	0.000211	0.00459	CcSEcCtD
Lacosamide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00021	0.00458	CcSEcCtD
Lacosamide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000208	0.00453	CcSEcCtD
Lacosamide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000207	0.00451	CcSEcCtD
Lacosamide—SCN3A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000206	0.0164	CbGpPWpGaD
Lacosamide—Asthenia—Furosemide—dilated cardiomyopathy	0.000205	0.00446	CcSEcCtD
Lacosamide—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.000202	0.0161	CbGpPWpGaD
Lacosamide—Pruritus—Furosemide—dilated cardiomyopathy	0.000202	0.0044	CcSEcCtD
Lacosamide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000195	0.00425	CcSEcCtD
Lacosamide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000194	0.00422	CcSEcCtD
Lacosamide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000192	0.00419	CcSEcCtD
Lacosamide—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000191	0.0152	CbGpPWpGaD
Lacosamide—Somnolence—Lisinopril—dilated cardiomyopathy	0.00019	0.00415	CcSEcCtD
Lacosamide—Dizziness—Furosemide—dilated cardiomyopathy	0.000189	0.00411	CcSEcCtD
Lacosamide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000188	0.00411	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000185	0.00403	CcSEcCtD
Lacosamide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000185	0.00402	CcSEcCtD
Lacosamide—Constipation—Lisinopril—dilated cardiomyopathy	0.000183	0.00399	CcSEcCtD
Lacosamide—Vomiting—Furosemide—dilated cardiomyopathy	0.000181	0.00395	CcSEcCtD
Lacosamide—Rash—Furosemide—dilated cardiomyopathy	0.00018	0.00392	CcSEcCtD
Lacosamide—Dermatitis—Furosemide—dilated cardiomyopathy	0.00018	0.00392	CcSEcCtD
Lacosamide—Headache—Furosemide—dilated cardiomyopathy	0.000179	0.0039	CcSEcCtD
Lacosamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000176	0.00384	CcSEcCtD
Lacosamide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00017	0.00371	CcSEcCtD
Lacosamide—Nausea—Furosemide—dilated cardiomyopathy	0.000169	0.00369	CcSEcCtD
Lacosamide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000169	0.00369	CcSEcCtD
Lacosamide—SCN9A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000163	0.013	CbGpPWpGaD
Lacosamide—SCN9A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000159	0.0127	CbGpPWpGaD
Lacosamide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000158	0.00344	CcSEcCtD
Lacosamide—SCN3A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000156	0.0124	CbGpPWpGaD
Lacosamide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000154	0.00335	CcSEcCtD
Lacosamide—SCN3A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000152	0.0121	CbGpPWpGaD
Lacosamide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000151	0.0033	CcSEcCtD
Lacosamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000146	0.00319	CcSEcCtD
Lacosamide—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000144	0.0115	CbGpPWpGaD
Lacosamide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000142	0.00308	CcSEcCtD
Lacosamide—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000141	0.0113	CbGpPWpGaD
Lacosamide—CA3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00014	0.0111	CbGpPWpGaD
Lacosamide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000136	0.00297	CcSEcCtD
Lacosamide—Rash—Lisinopril—dilated cardiomyopathy	0.000135	0.00294	CcSEcCtD
Lacosamide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000135	0.00294	CcSEcCtD
Lacosamide—Headache—Lisinopril—dilated cardiomyopathy	0.000134	0.00292	CcSEcCtD
Lacosamide—CA3—Metabolism—TAZ—dilated cardiomyopathy	0.000131	0.0105	CbGpPWpGaD
Lacosamide—SCN9A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000128	0.0102	CbGpPWpGaD
Lacosamide—Nausea—Lisinopril—dilated cardiomyopathy	0.000127	0.00277	CcSEcCtD
Lacosamide—SCN3A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000123	0.00976	CbGpPWpGaD
Lacosamide—CA3—Metabolism—SDHA—dilated cardiomyopathy	0.000119	0.00946	CbGpPWpGaD
Lacosamide—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000114	0.00905	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—PSEN2—dilated cardiomyopathy	9.63e-05	0.00767	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—PSEN2—dilated cardiomyopathy	9.21e-05	0.00734	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ANKRD1—dilated cardiomyopathy	8.99e-05	0.00717	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ANKRD1—dilated cardiomyopathy	8.76e-05	0.00698	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	8.53e-05	0.0068	CbGpPWpGaD
Lacosamide—CA14—Metabolism—TAZ—dilated cardiomyopathy	8.45e-05	0.00674	CbGpPWpGaD
Lacosamide—CA6—Metabolism—TAZ—dilated cardiomyopathy	8.24e-05	0.00657	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ANKRD1—dilated cardiomyopathy	8.18e-05	0.00652	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—TAZ—dilated cardiomyopathy	7.69e-05	0.00613	CbGpPWpGaD
Lacosamide—CA14—Metabolism—SDHA—dilated cardiomyopathy	7.64e-05	0.00609	CbGpPWpGaD
Lacosamide—CA6—Metabolism—SDHA—dilated cardiomyopathy	7.45e-05	0.00594	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—SDHA—dilated cardiomyopathy	6.96e-05	0.00554	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	6.87e-05	0.00547	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—PSEN2—dilated cardiomyopathy	6.57e-05	0.00524	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	6.09e-05	0.00485	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ANKRD1—dilated cardiomyopathy	6.04e-05	0.00482	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	6.02e-05	0.0048	CbGpPWpGaD
Lacosamide—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	5.82e-05	0.00464	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ANKRD1—dilated cardiomyopathy	5.79e-05	0.00462	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—ITGB1—dilated cardiomyopathy	5.76e-05	0.00459	CbGpPWpGaD
Lacosamide—CA4—Metabolism—TAZ—dilated cardiomyopathy	5.68e-05	0.00453	CbGpPWpGaD
Lacosamide—SCN3A—L1CAM interactions—EGFR—dilated cardiomyopathy	5.57e-05	0.00444	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ANKRD1—dilated cardiomyopathy	5.55e-05	0.00443	CbGpPWpGaD
Lacosamide—CA2—Metabolism—TAZ—dilated cardiomyopathy	5.45e-05	0.00434	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	5.34e-05	0.00425	CbGpPWpGaD
Lacosamide—CA1—Metabolism—TAZ—dilated cardiomyopathy	5.22e-05	0.00416	CbGpPWpGaD
Lacosamide—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	5.16e-05	0.00411	CbGpPWpGaD
Lacosamide—CA4—Metabolism—SDHA—dilated cardiomyopathy	5.14e-05	0.0041	CbGpPWpGaD
Lacosamide—CA2—Metabolism—SDHA—dilated cardiomyopathy	4.93e-05	0.00393	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—SOD2—dilated cardiomyopathy	4.91e-05	0.00391	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ANKRD1—dilated cardiomyopathy	4.88e-05	0.00389	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	4.84e-05	0.00386	CbGpPWpGaD
Lacosamide—CA1—Metabolism—SDHA—dilated cardiomyopathy	4.72e-05	0.00376	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—GPX1—dilated cardiomyopathy	4.68e-05	0.00373	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—RAC1—dilated cardiomyopathy	4.63e-05	0.00369	CbGpPWpGaD
Lacosamide—CA9—Metabolism—TAZ—dilated cardiomyopathy	4.59e-05	0.00366	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	4.3e-05	0.00342	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	4.29e-05	0.00342	CbGpPWpGaD
Lacosamide—CA9—Metabolism—SDHA—dilated cardiomyopathy	4.15e-05	0.00331	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—ITGB1—dilated cardiomyopathy	4.11e-05	0.00328	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.81e-05	0.00303	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	3.67e-05	0.00292	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	3.51e-05	0.00279	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	3.45e-05	0.00275	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	3.3e-05	0.00263	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	3.25e-05	0.00259	CbGpPWpGaD
Lacosamide—CA3—Metabolism—GPX1—dilated cardiomyopathy	3.22e-05	0.00257	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	3.21e-05	0.00256	CbGpPWpGaD
Lacosamide—CA3—Metabolism—CD36—dilated cardiomyopathy	3.14e-05	0.0025	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	3.07e-05	0.00245	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	3.06e-05	0.00244	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	2.84e-05	0.00227	CbGpPWpGaD
Lacosamide—CA3—Metabolism—AGT—dilated cardiomyopathy	2.83e-05	0.00225	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	2.29e-05	0.00183	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	2.2e-05	0.00175	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	2.19e-05	0.00175	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	2.11e-05	0.00168	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GPX1—dilated cardiomyopathy	2.08e-05	0.00166	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	2.03e-05	0.00162	CbGpPWpGaD
Lacosamide—CA6—Metabolism—GPX1—dilated cardiomyopathy	2.02e-05	0.00161	CbGpPWpGaD
Lacosamide—CA14—Metabolism—CD36—dilated cardiomyopathy	2.02e-05	0.00161	CbGpPWpGaD
Lacosamide—CA6—Metabolism—CD36—dilated cardiomyopathy	1.97e-05	0.00157	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	1.95e-05	0.00155	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GPX1—dilated cardiomyopathy	1.89e-05	0.00151	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—CD36—dilated cardiomyopathy	1.84e-05	0.00147	CbGpPWpGaD
Lacosamide—CA14—Metabolism—AGT—dilated cardiomyopathy	1.82e-05	0.00145	CbGpPWpGaD
Lacosamide—CA6—Metabolism—AGT—dilated cardiomyopathy	1.77e-05	0.00141	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—AGT—dilated cardiomyopathy	1.66e-05	0.00132	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	1.57e-05	0.00125	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	1.5e-05	0.0012	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	1.5e-05	0.00119	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	1.43e-05	0.00114	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GPX1—dilated cardiomyopathy	1.4e-05	0.00111	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	1.39e-05	0.00111	CbGpPWpGaD
Lacosamide—CA4—Metabolism—CD36—dilated cardiomyopathy	1.36e-05	0.00108	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GPX1—dilated cardiomyopathy	1.34e-05	0.00107	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	1.33e-05	0.00106	CbGpPWpGaD
Lacosamide—CA2—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.00104	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GPX1—dilated cardiomyopathy	1.28e-05	0.00102	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CD36—dilated cardiomyopathy	1.25e-05	0.000996	CbGpPWpGaD
Lacosamide—CA4—Metabolism—AGT—dilated cardiomyopathy	1.22e-05	0.000975	CbGpPWpGaD
Lacosamide—CA2—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000935	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GPX1—dilated cardiomyopathy	1.13e-05	0.000899	CbGpPWpGaD
Lacosamide—CA1—Metabolism—AGT—dilated cardiomyopathy	1.13e-05	0.000897	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CD36—dilated cardiomyopathy	1.1e-05	0.000875	CbGpPWpGaD
Lacosamide—CA9—Metabolism—AGT—dilated cardiomyopathy	9.89e-06	0.000788	CbGpPWpGaD
